MS

Opexa soars on talks with FDA over MS drug
Marketwatch
Wed, 01/5/11 - 11:10 am
FDA
MS
Opexa
multiple sclerosis
Tovaxin
Biogen Idec begins selling Tysabri in India
Bizjournals.com
Tue, 12/28/10 - 01:11 pm
Indian
Tysabri
Biogen Idec
MS
multiple sclerosis
Teva Pharma Rises on Optimism of Reduced Competition for Copaxone MS Drug
Bloomberg
Mon, 12/27/10 - 08:24 am
Teva Pharmaceuticals
Copaxone
multiple sclerosis
MS
FDA
Teva May Face Copaxone Copy From Novartis, Momenta as Soon as Next Month
Bloomberg
Thu, 12/23/10 - 08:38 am
Teva Pharmaceuticals
Novartis
Copaxone
Momenta
generics
MS
multiple sclerosis
Biogen Idec, Elan seek to update Tysabri labeling
Marketwatch
Wed, 12/22/10 - 09:00 am
Elan
Biogen Idec
Tysabri
MS
multiple sclerosis
Novartis Pill for Untreatable Multiple Sclerosis Might Reap $5.4 Billion
Bloomberg
Tue, 12/21/10 - 10:48 am
Novartis
MS
multiple sclerosis
Gilenya
Biogen reports four more Tysabri cases, one death
Reuters
Fri, 12/17/10 - 11:34 am
Biogen Idec
PML
Tysabri
MS
Merck KGaA Says FDA Extends Review of MS Pill in Setback Against Novartis
Bloomberg
Sat, 11/27/10 - 01:15 pm
Merck KGaA
FDA
MS
multiple sclerosis
Novartis
Darmstadt
Termeer Touts Campath-Linked CVRs
InVivo
Sat, 11/27/10 - 12:59 pm
Henri Termeer
Campath
MS
Genzyme
multiple sclerosis
Sanofi
Can Genzyme Make $3.5B a Year Giving Away a Drug for Free?
BNET Pharma
Sat, 11/27/10 - 12:53 pm
Genzyme
alemtuzumab
Sanofi
MS
multiple sclerosis
Genzyme Considers a Way Around Campath Impasse
WSJ Online
Mon, 11/22/10 - 10:31 am
Campath
Genzyme
multiple sclerosis
MS
Novartis’s Gilenya to Take 13% of Market in Year, Leerink Says
Bloomberg
Wed, 11/10/10 - 11:02 am
Novartis
Gilenya
MS
multiple sclerosis
Sanofi-Aventis starts Phase III oral-MS-drug test
Marketwatch
Tue, 10/26/10 - 11:17 am
MS
multiple sclerosis
Sanofi
teriflunomide
Sanofi MS drug data show relapses cut by 31 pct
Reuters
Fri, 10/15/10 - 10:35 am
Sanofi
MS
multiple sclerosis
teriflunomide
Genzyme Says Campath MS Success Helps Justify Higher Sanofi Buyout Offer
Bloomberg
Thu, 10/14/10 - 05:19 pm
Genzyme
Campath
MS
multiple sclerosis
M&A
Sanofi
Genzyme sees signs of remission in 5-year MS drug data
Fierce Biotech
Thu, 10/14/10 - 11:53 am
MS
multiple sclerosis
Campath
Genzyme
Novartis to pay Gilenya patients' bills
Fierce Pharma
Thu, 10/7/10 - 11:52 am
Novartis
Gilenya
MS
multiple sclerosis
Novartis Gilenya Launch: The Importance of Health Care Reform
InVivo
Wed, 10/6/10 - 10:11 am
healthcare reform
Gilenya
Novartis
MS
multiple sclerosis
From Cicada Fungus To MS Drug: How Big Will Novartis’ New Pill Be?
Forbes
Mon, 09/27/10 - 11:59 am
Novartis
MS
multiple sclerosis
Gilenya
Merck KGaA drops 10 per cent after drug rejection
FT.com
Fri, 09/24/10 - 09:57 am
Merck KGaA
MS
multiple sclerosis

Pages